BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

High Court Rules for AstraZeneca PLC (AZN) Over Deaths from Iressa


5/29/2012 7:48:11 AM

The Osaka High Court has reversed a lower court ruling that found the Japanese arm of London-based pharmaceutical company AstraZeneca PLC responsible for deaths caused by side effects of its lung cancer drug Iressa. The court also denied Friday the government's responsibility in approving the drug in July 2002, upholding the decision of the lower court. In July 2004, a patient and the families of three patients who died after taking the drug sued the government and AstraZeneca K.K., based in Osaka, seeking 100 million yen in damages. In February last year, the company was ordered by the Osaka District Court to pay about 60 million yen to the plaintiffs.

Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES